Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Aduro and Johns Hopkins University to evaluate Aduro vaccine technologies with anti-PD-1

April 23, 2013

Merck Serono obtains marketing rights to Cetrotide

April 23, 2013

Ono obtains rights to opicapone for Parkinson's disease in Japan

April 23, 2013

BIND Therapeutics and AstraZeneca collaborate on cancer nanomedicine

April 22, 2013

Cerecor acquires rights to MK-0657 from Merck & Co.

April 22, 2013

Pieris achieves second milestone under Anticalin collaboration

April 22, 2013

Shin Nippon Biomedical and Besins Healthcare sign nasal drug delivery agreement

April 19, 2013

SK Biopharmaceuticals and SK Chemicals establish alliance for YKP-10811

April 19, 2013

Interprotein and Takeda sign new molecular design agreement

April 19, 2013

Stem Cell Therapeutics licenses rights to cancer stem cell program

April 19, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...